NASDAQ:CVETCovetrus Stock Price, Forecast & News

Covetrus' stock was trading at $9.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CVET stock has increased by 118.3% and is now trading at $19.73. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Covetrus in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Covetrus.

Covetrus is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for Covetrus.

Covetrus Inc (NASDAQ:CVET) issued its quarterly earnings results on Thursday, May, 14th. The company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.06. The firm earned $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. Covetrus had a positive return on equity of 4.84% and a negative net margin of 24.05%. View Covetrus' earnings history.

Covetrus updated its first quarter 2020 Pre-Market earnings guidance on Wednesday, April, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.07-1.07 billion, compared to the consensus revenue estimate of $969.68 million.

4 equities research analysts have issued 12 month target prices for Covetrus' stock. Their forecasts range from $11.00 to $21.00. On average, they anticipate Covetrus' share price to reach $15.50 in the next year. This suggests that the stock has a possible downside of 21.4%. View analysts' price targets for Covetrus.

Media stories about CVET stock have been trending very negative this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Covetrus earned a news sentiment score of -3.6 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Covetrus.

Covetrus saw a decrease in short interest in June. As of June 30th, there was short interest totaling 10,690,000 shares, a decrease of 10.3% from the June 15th total of 11,920,000 shares. Based on an average trading volume of 1,590,000 shares, the days-to-cover ratio is currently 6.7 days. Currently, 11.0% of the shares of the company are short sold. View Covetrus' Current Options Chain.

Some companies that are related to Covetrus include Rite Aid (RAD), Petmed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Covetrus investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), AT&T (T), Verizon Communications (VZ), Evolent Health (EVH), Alphabet (GOOG), IDEXX Laboratories (IDXX), Las Vegas Sands (LVS), Nokia Oyj (NOK) and Pfizer (PFE).

Covetrus trades on the NASDAQ under the ticker symbol "CVET."

Shares of CVET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CVET stock can currently be purchased for approximately $19.73.

Covetrus has a market capitalization of $2.21 billion and generates $3.98 billion in revenue each year. The company earns $-1,019,000,000.00 in net income (profit) each year or $0.79 on an earnings per share basis. Covetrus employs 5,500 workers across the globe.

The official website for Covetrus is www.henryscheinvet.com.

Covetrus' mailing address is 7 CUSTOM HOUSE STREET, PORTLAND ME, 04101. The company can be reached via phone at 888-280-2221 or via email at [email protected]